BCR 2.0
Switchable Antigen-Sensing System (S.A.S.S.)
Center |
---|
Friday
To do's
To Do's:
- Midiprep (from freezer)
- S9TEV
- B15T15
- Golden Gate
- B9T9
- B15T9
- LR
- Midi:
- hEF1a:CymR
- hEF1a-CuO:mKate
- CMV5-CuO:mKate
- GG DONR
- digest, gel:
- hEF1a:CymR
- hEF1a-CuO:mKateGmab H
- CMV5hEF1a-CuO:mKate
- transform TRE:Syk-15-tTEVp golden gate
Thursday's To Do's
- gel verify:
- hEF1a:CymR
- hEF1aGmab L
- hEF1a-CuO:mKateCD79A
- CMV5hEF1a-CuO:mKate
- Syk-15-tTEVp PCR
- hEF1a:CymR
- CD79B
- hEF1a-CuO:mKate
- CMV5-CuO:mKate
- PCR purify TRE:Syk-15-tTEVp
- Golden gate TRE:Syk-15-tTEVp
- LR - probably can't do today because no LR clonase
- EGSH:mKate
- hEf1a:VgEcR-2A-RXR
- TRE:mKate
- hEF1a:Gal4VP16 (remember which pDEST)
- hEF1a:CD79B-TCS-Gal4VP16
Wednesday's To Do's
- Flow cytometry with Brian
- Order chicken lysozyme and gp120?
- Non-lab to do's
- Design (or find?) sequencing primers for mIgM CH (constant region)
- Plan experiment to test gantenerumab binding to beta-amyloid
- Leader sequences for ordering gBlocks of variable regions?
CMV5-CuO 715:
hEF1a-CuO 715:09
CymR-CuO 710:09
Geneious To Do List:
- Antibody cloning for chicken lysozyme - Kathryn
hef1a sequencing primers
- Lyn
- Digest all of the Syk-TEVp and Syk-tTEVp midis just to be sure (since there's an internal cut site that didn't get read in sequencing)
Sequencing account information:BCR 2.0 To Do
^^^Email: bcrpeeps@mit.edu
^^^Pass: grapefruit
## Digest tTEVp and TEVp midis just to be sure (since there's an internal cut site)
Non-Lab To Do's
- Bug Brian about ordering antibody testing supplies
Higher Level To Do's:
- Decide on other antigen-variable regions we want to test
- Other experimental planning (on experimental page)
- Parts list (excel sheet detailing specs/locations of parts)
- How do we do site directed mutagenesis?
- Literature research:
- kozak sequences for heavy and light chains and CD79s
- truncated TEVp
- other antigens to detect using BCR (we were thinking of small molecule detection)
- Cloning planning
- hEF1a:Syk-pTet:mRFP-TEVp
- variable region
- Is gantenerumab proprietary and can we actually publish with it?